Rui Bergantim

Multiple Myeloma: Available Therapies and Causes of Drug Resistance

M. Vasconcelos, M. Vasconcelos, H. Seca, 2020, Cancers.

Effect of miR-128 in DNA damage of HL-60 acute myeloid leukemia cells.

M. Sobrinho-Simões, R. Lima, M. Vasconcelos, 2014, Current pharmaceutical biotechnology.

Detection of Measurable Residual Disease Biomarkers in Extracellular Vesicles from Liquid Biopsies of Multiple Myeloma Patients—A Proof of Concept

M. Vasconcelos, André Albergaria, R. Bergantim, 2022, International journal of molecular sciences.

The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance

M. Vasconcelos, C. P. Xavier, R. Bergantim, 2020, Cells.

An Assessment of the Effectiveness and Safety of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma Patients with Relapsed or Refractory Disease: A Systematic Review and Meta-Analysis

Rui Bergantim, Rita Pereira, 2024, International journal of molecular sciences.